Emerging Cellular Therapies in Hematologic Malignancies
An overview of promising novel cellular therapies showing efficacy against hematologic cancers in early-phase clinical trials.
Source: onclive.com
Page 8 - Hematologic Malignancies News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hematologic Malignancies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hematologic Malignancies Today - Breaking & Trending Today
Transplant in the Elderly Population
This session will focus on considerations and outcomes of allo-HSCT specifically among patients over 55 years of age. The panel will discuss how transplant protocols and supportive care measures can be optimized for this population who are at higher risk of comorbidities, toxicity and poor functional status.
Source: onclive.com
Inhibikase Therapeutics Announces Preliminary Outcomes of its Pre-NDA Meeting with the FDA on the Pathway for Approval for IkT-001Pro in Blood and Gastrointestinal Cancers
- The Company continues to progress the 201 Trial evaluating risvodetinib in untreated Parkinson’s disease -BOSTON and ATLANTA, Feb. 07, 2024 -- Inhibikase Therapeutics, Inc. , a...
Source: marketscreener.com
Lonial Spotlights CAR T-Cell and Off-the-Shelf Treatments in Multiple Myeloma
Sagar Lonial, MD, FACP, details how CAR T-cell therapies and off-the-shelf treatments are improving outcomes for patients with multiple myeloma.
Source: onclive.com
Patient Case Studies of GvHD
Provide detailed case studies highlighting the development, clinical presentation, multidisciplinary management, and outcomes of patients with acute and chronic GvHD following allo-HSCT.
Source: onclive.com